Results 201 to 210 of about 58,225 (243)
Some of the next articles are maybe not open access.
Hepatology, 1987
To evaluate the effect of hepatitis delta virus on the level of replication of hepatitis B virus and to assess the clinical significance that such an effect might have on the final outcome of the infection, the serological profile of hepatitis B virus DNA was investigated in 153 patients with acute or chronic hepatitis B virus
J, Genesca +7 more
openaire +2 more sources
To evaluate the effect of hepatitis delta virus on the level of replication of hepatitis B virus and to assess the clinical significance that such an effect might have on the final outcome of the infection, the serological profile of hepatitis B virus DNA was investigated in 153 patients with acute or chronic hepatitis B virus
J, Genesca +7 more
openaire +2 more sources
Replication of hepatitis delta virus
Journal of Viral Hepatitis, 1996SUMMARY. Hepatitis delta virus (HDV) is a unique viroid‐like human pathogen that is always associated with hepatitis B infection. Replication of HDV involves the transcription of genomic RNA, probably by the host RNA polymerase II, by a rolling circle mechanism followed by self‐cleavage and self‐ligation. Editing of antigenomic RNA, possibly involving
openaire +2 more sources
Delta Hepatitis and the Hepatitis Delta Virus
1989Since its discovery in 1977 by Rizzetto and co-workers from Turin, Italy, the hepatitis delta virus (HDV) has become a focus of worldwide interest—interest almost equal to its worldwide importance.1, 2 The delta antigen, which first appeared to be a poorly explained finding of immunofluorescence staining in liver biopsies from Italian chronic hepatitis
openaire +1 more source
Hepatitis Delta Virus Infection and Labrea Hepatitis
JAMA: The Journal of the American Medical Association, 1988To the Editor. —In an interesting article, Bensabath et al 1 suggest that delta virus infection is the preponderant cause of Labrea hepatitis. They declare that the clinical picture of the classic form of massive hepatic necrosis is indistinguishable from the fulminant steatosis observed in Labrea hepatitis.
openaire +2 more sources
Delta hepatitis virus infection in ethiopia
European Journal of Epidemiology, 1988The results of Hepatitis Delta virus (HDV) antibody determinations carried on 566 HBsAg positive serum samples from a population of 5270 Ethiopian military recruits are reported. The prevalence of anti-HDV among apparently healthy HBsAg carriers was 5.8%. The prevalence increases with age within the available range (18-30 years).
M. Rapicetta +10 more
openaire +2 more sources
Delta in Denmark: prevalence of hepatitis delta virus infection
Infectious DiseasesHepatitis delta virus (HDV) infection has an aggressive disease course and is the most difficult to treat of the human hepatitis viruses. In Denmark, as in many countries, the national prevalence of HDV has not been established. Based on diagnoses and laboratory test results in national healthcare registries, we estimated that the prevalence of current
Hugh Watson +3 more
openaire +4 more sources
Hepatitis delta virus pathogenicity.
Progress in clinical and biological research, 1993This review has presented data consistent with the hypothesis that HDV may be directly cytopathic or non-cytopathic depending on the stage of infection. Nevertheless, although a majority of HDV-infected patients show evidence of liver disease, healthy carriers of the virus lead to the suggestion that different healthy carriers of HDV can exist, but ...
E J, Gowans, F, Bonino
openaire +1 more source
Hepatitis D virus (HDV) (Hepatitis delta)
1994Infection with hepatitis delta virus is dependent on the simultaneous presence of hepatitis B virus and reaches a maximum in persons with the highest levels of HBV replication. Classification of HDV remains uncertain; distinct from any known human virus, the RNA genome of HDV is similar to that of plant viroids.
Hugh Young, Marie Ogilvie
openaire +1 more source
Cervical cancer prevention and control in women living with human immunodeficiency virus
Ca-A Cancer Journal for Clinicians, 2021Philip E Castle, Vikrant V Sahasrabuddhe
exaly

